Ranbaxy Gets Dibs On Generic Alzheimer's Drug
India's Ranbaxy Laboratories Ltd. has secured approval from the U.S. Food and Drug Administration to sell a generic version of Eisai Co.'s Alzheimer's treatment Aricept, scoring a win in a battle...To view the full article, register now.
Already a subscriber? Click here to view full article